ropivacaine hydrochloride
ropivacaine hydrochloride is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including ropivacaine hydrochloride, Naropin, ROPIVACAINE HYDROCHLORIDE. Available dosage forms: injection, solution, injection, powder.
Drug details
- Generic Name
- ropivacaine hydrochloride
- Brand Names
- ropivacaine hydrochloride, Naropin, ROPIVACAINE HYDROCHLORIDE, NAROPIN
- Application Number
- ANDA206166
- Sponsor
- Sagent Pharmaceuticals
- NDC Codes
- 11
- Dosage Forms
- INJECTION, SOLUTION, INJECTION, POWDER
- Routes
- EPIDURAL, INFILTRATION, PERINEURAL
- Active Ingredients
- ROPIVACAINE HYDROCHLORIDE
Indications and Usage
1 Indications and Usage NAROPIN is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration Acute Pain Management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration NAROPIN is an amide local anesthetic indicated in adults for the production of local or regional anesthesia for surgery and for acute pain management. (1) Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration Acute Pain Management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration